Ceritinib Capsules IP

Key Benefits
- Used for certain ALK-positive non-small cell lung cancers
- Helps inhibit abnormal cancer cell growth
- Provides targeted therapy for tumors with ALK alterations
- May be used when treatment with other ALK-targeted medicines is not suitable or as prescribed
- Supports personalized cancer treatment under specialist care
How It Works
Ceritinib is an ALK tyrosine kinase inhibitor. It blocks abnormal ALK proteins that send growth signals to cancer cells, helping slow or inhibit the growth and spread of ALK-positive cancer cells.
Common Side Effects
- Diarrhea
- Nausea
- Vomiting
- Abdominal pain
- Loss of appetite
- Fatigue
- Weight loss
- Increased liver enzymes
- Increased blood sugar levels
Important Information
Ceritinib Capsules IP should be used only under the supervision of an experienced oncologist. Regular monitoring may be required for liver function, blood sugar levels, heart rhythm, and other treatment-related effects. Inform your healthcare professional about existing liver, heart, or pancreatic problems and all medicines you are taking. Seek medical attention if severe abdominal pain, breathing difficulty, unusual heartbeat, or signs of serious liver problems occur.